Cáncer de Ovario encontrar mi medicamentos cáncer Consolidation Radiotherapy After Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian Cancer Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives. SHARE Study Group. Steroid Hormones and Reproductions Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives Oral contraceptives and the risk of hereditary ovarian cancer Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Consolidation Radiotherapy After Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian Cancer
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives. SHARE Study Group. Steroid Hormones and Reproductions
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study